JP2010537641A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010537641A5 JP2010537641A5 JP2010523124A JP2010523124A JP2010537641A5 JP 2010537641 A5 JP2010537641 A5 JP 2010537641A5 JP 2010523124 A JP2010523124 A JP 2010523124A JP 2010523124 A JP2010523124 A JP 2010523124A JP 2010537641 A5 JP2010537641 A5 JP 2010537641A5
- Authority
- JP
- Japan
- Prior art keywords
- virus
- cell
- liquid
- viral antigen
- viral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US96672407P | 2007-08-28 | 2007-08-28 | |
| US60/966,724 | 2007-08-28 | ||
| PCT/US2008/074559 WO2009029695A1 (en) | 2007-08-28 | 2008-08-28 | Method for producing viral vaccines |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010537641A JP2010537641A (ja) | 2010-12-09 |
| JP2010537641A5 true JP2010537641A5 (enExample) | 2011-10-20 |
| JP5535910B2 JP5535910B2 (ja) | 2014-07-02 |
Family
ID=39947984
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010523124A Active JP5535910B2 (ja) | 2007-08-28 | 2008-08-28 | ウイルスワクチンを生産する方法 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US8497112B2 (enExample) |
| EP (1) | EP2192917B1 (enExample) |
| JP (1) | JP5535910B2 (enExample) |
| KR (1) | KR101760844B1 (enExample) |
| CN (1) | CN101790381B (enExample) |
| AU (1) | AU2008293513B2 (enExample) |
| BR (1) | BRPI0816130A2 (enExample) |
| CA (1) | CA2696090C (enExample) |
| ES (1) | ES2459166T3 (enExample) |
| HR (1) | HRP20140375T1 (enExample) |
| IL (1) | IL203869A (enExample) |
| PL (1) | PL2192917T3 (enExample) |
| RU (1) | RU2496519C2 (enExample) |
| SG (1) | SG10201404101RA (enExample) |
| SI (1) | SI2192917T1 (enExample) |
| WO (1) | WO2009029695A1 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11707520B2 (en) | 2005-11-03 | 2023-07-25 | Seqirus UK Limited | Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture |
| US20090220541A1 (en) * | 2005-11-04 | 2009-09-03 | Novartis Vaccines And Diagnostics Srl | Emulsions with free aqueous-phase surfactant for adjuvanting split influenza vaccines |
| CN101784283A (zh) * | 2007-06-27 | 2010-07-21 | 诺华有限公司 | 低添加流感疫苗 |
| AU2010212550B2 (en) | 2009-02-10 | 2016-03-10 | Seqirus UK Limited | Influenza vaccines with reduced amounts of squalene |
| CA2803282C (en) | 2009-07-06 | 2018-05-01 | David E. Anderson | Methods for preparing vesicles and formulations produced therefrom |
| CN102482666B (zh) | 2009-07-06 | 2017-02-08 | 变异生物技术公司 | 制备囊泡的方法和由其产生的制剂 |
| GB0918830D0 (en) * | 2009-10-27 | 2009-12-09 | Glaxosmithkline Biolog Niederl | Process |
| CN102858961A (zh) * | 2010-05-03 | 2013-01-02 | 葛兰素史密丝克莱恩生物有限公司 | 新方法 |
| CN103096922B (zh) | 2010-07-06 | 2019-08-06 | 变异生物技术公司 | 用于治疗流行性感冒的组合物和方法 |
| US20130323280A1 (en) | 2011-01-13 | 2013-12-05 | Variation Biotechnologies, Inc. | Methods for preparing vesicles and formulations produced therefrom |
| BR112013017939B1 (pt) | 2011-01-13 | 2022-11-16 | Variation Biotechnologies Inc | Composição imunogênica liofilizada termoestável, uso e método para preparação da mesma |
| RU2565827C2 (ru) * | 2011-07-20 | 2015-10-20 | Эбботт Байолоджикалз Б.В. | Способ получения вирусного антигена и вакцин |
| EP2737060B1 (en) * | 2011-07-27 | 2019-03-06 | Flash Therapeutics | Method for the production of retroviral particles useful for transducing eukaryotic cells |
| US20140328876A1 (en) | 2011-11-18 | 2014-11-06 | Variation Biotechnologies Inc. | Synthetic derivatives of mpl and uses thereof |
| EP2802353A4 (en) | 2012-01-12 | 2015-12-02 | Variation Biotechnologies Inc | COMPOSITIONS AND METHOD FOR THE TREATMENT OF VIRUS INFECTIONS |
| CN104244984B (zh) | 2012-01-27 | 2020-03-31 | 变异生物技术公司 | 用于治疗剂的方法和组合物 |
| JP6522606B2 (ja) * | 2013-10-22 | 2019-05-29 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 乾燥血斑からの細胞遊離性ウイルス粒子の測定方法 |
| FR3025107B1 (fr) | 2014-08-29 | 2018-10-05 | Calixar | Procede de preparation d'un antigene vaccinal, antigene vaccinal obtenu et utilisations |
| JP7432506B2 (ja) | 2017-10-30 | 2024-02-16 | 武田薬品工業株式会社 | 脂質エンベロープウイルスを不活化するための環境適合性の界面活性剤 |
| CN111979120B (zh) * | 2019-05-23 | 2022-09-27 | 比欧联科供应链管理(北京)有限公司 | 一种狂犬疫苗核酸消化去除装置及实验方法 |
| RU2754398C1 (ru) * | 2020-06-25 | 2021-09-01 | Общество с ограниченной ответственностью «ФОРТ» | Способ получения четырехвалентной вакцины для профилактики гриппа |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH589453A5 (enExample) * | 1974-01-14 | 1977-07-15 | Sandoz Ag | |
| FR2475572A1 (fr) | 1980-02-11 | 1981-08-14 | Pasteur Institut | Procede pour l'obtention de fragments de virus a enveloppe lipidique, en particulier d'antigenes utilisables comme vaccins, produits obtenus et applications |
| FR2533548B1 (fr) * | 1982-09-28 | 1985-07-26 | Degremont | Procede et appareil de traitement anaerobie d'eaux residuaires dans un filtre a remplissage de materiau granulaire |
| EP0172433A3 (en) * | 1984-08-02 | 1989-04-05 | Tektronix, Inc. | Display method and apparatus employing cursor panning |
| GB9110808D0 (en) * | 1991-05-17 | 1991-07-10 | Retroscreen Ltd | Aids vaccine and method for its production |
| RU2082433C1 (ru) * | 1992-07-13 | 1997-06-27 | Николай Владимирович Костючек | Способ вакцинопрофилактики гриппа |
| FR2723740B1 (fr) | 1994-08-16 | 1996-11-08 | Pasteur Merieux Serums Vacc | Procede de preparation d'antigenes du virus grippal, antigenes obtenus et leurs applications |
| CN1223589A (zh) * | 1996-05-06 | 1999-07-21 | 美国拜尔公司 | 包含鹦鹉热衣原体的猫疫苗及其制备方法 |
| AT405939B (de) * | 1997-02-24 | 1999-12-27 | Immuno Ag | Verfahren zur inaktivierung von lipidumhüllten viren |
| KR20010032699A (ko) * | 1998-10-05 | 2001-04-25 | 무따이 마사히꼬 | 일본 뇌염 바이러스 감염에 대한 불활성 백신을 위한증강된 면역원 및 그 제조방법 |
| CA2355270A1 (en) * | 1998-12-17 | 2000-06-22 | Aventis Pasteur Limited | Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation |
| US7521220B2 (en) * | 1999-11-26 | 2009-04-21 | Crucell Holland B.V. | Production of vaccines |
| MXPA03000729A (es) | 2000-07-28 | 2004-11-01 | Inspire Pharmaceuticals Inc | Metodo para reducir la presion intraocular utilizando derivados de indol. |
| GB0024089D0 (en) * | 2000-10-02 | 2000-11-15 | Smithkline Beecham Biolog | Novel compounds |
| TWI228420B (en) * | 2001-05-30 | 2005-03-01 | Smithkline Beecham Pharma Gmbh | Novel vaccine composition |
| RU2195959C1 (ru) * | 2001-11-02 | 2003-01-10 | Федеральное государственное учреждение Всероссийский научно-исследовательский институт защиты животных | Инактивированная вакцина против синдрома гидроперикардита кур |
| RU2261111C1 (ru) * | 2004-04-08 | 2005-09-27 | Сергеев Виталий Александрович | Инактивированная вакцина против вирусных пневмогастроэнтеритов крупного рогатого скота и телят и способ профилактики вирусных пневмогастроэнтеритов |
| US8703467B2 (en) * | 2004-05-27 | 2014-04-22 | Baxter International Inc. | Inactivation of a pathogen in a sample by a treatment with formalin and UV light |
| CN1647822A (zh) * | 2005-02-06 | 2005-08-03 | 北京生物制品研究所 | 脊髓灰质炎灭活疫苗及其制备方法 |
| EP1724338A1 (en) * | 2005-05-19 | 2006-11-22 | Crucell Holland B.V. | Methods for the production of a whole-inactivated West Nile Virus vaccine |
-
2008
- 2008-08-28 SG SG10201404101RA patent/SG10201404101RA/en unknown
- 2008-08-28 CA CA2696090A patent/CA2696090C/en active Active
- 2008-08-28 AU AU2008293513A patent/AU2008293513B2/en active Active
- 2008-08-28 WO PCT/US2008/074559 patent/WO2009029695A1/en not_active Ceased
- 2008-08-28 BR BRPI0816130-5A2A patent/BRPI0816130A2/pt not_active IP Right Cessation
- 2008-08-28 JP JP2010523124A patent/JP5535910B2/ja active Active
- 2008-08-28 PL PL08828326T patent/PL2192917T3/pl unknown
- 2008-08-28 ES ES08828326.2T patent/ES2459166T3/es active Active
- 2008-08-28 US US12/199,977 patent/US8497112B2/en active Active
- 2008-08-28 KR KR1020107006633A patent/KR101760844B1/ko active Active
- 2008-08-28 EP EP08828326.2A patent/EP2192917B1/en active Active
- 2008-08-28 SI SI200831190T patent/SI2192917T1/sl unknown
- 2008-08-28 RU RU2010111747/10A patent/RU2496519C2/ru not_active IP Right Cessation
- 2008-08-28 HR HRP20140375AT patent/HRP20140375T1/hr unknown
- 2008-08-28 CN CN200880105185.5A patent/CN101790381B/zh active Active
-
2010
- 2010-02-10 IL IL203869A patent/IL203869A/en active IP Right Grant
-
2013
- 2013-06-26 US US13/928,094 patent/US20130287811A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2010111747A (ru) | Способ получения противовирусных вакцин | |
| KR101548790B1 (ko) | 백신 제조를 위한 고역가 폴리오바이러스의 제조 | |
| JP2009034115A5 (enExample) | ||
| JP2012025784A5 (enExample) | ||
| JP2013515473A5 (enExample) | ||
| TW201311896A (zh) | 製備病毒抗原及疫苗之方法 | |
| JP2009225809A5 (enExample) | ||
| WO2015059714A1 (en) | Emergency mode in a hybrid vehicle | |
| DK3010537T3 (en) | PROCEDURE FOR PREVENTING AGGREGATION OF VIRUS COMPONENTS | |
| CN103394081B (zh) | 利用wave波浪生物反应器生产禽流感疫苗的方法 | |
| EA010057B1 (ru) | Инактивированная полиомиелитная вакцина, полученная из штамма сейбина вируса полиомиелита | |
| CN102599057A (zh) | 采用病毒唑脱除马铃薯病毒的方法 | |
| CN102796708A (zh) | 一种增殖甲型流感病毒的方法 | |
| CN108602860B (zh) | 通过去脂作用灭活病毒 | |
| CN102614508B (zh) | 一种人用流感病毒裂解疫苗的病毒裂解灭活方法 | |
| US8426124B2 (en) | Two-step temperature profile for the propagation of viruses | |
| CN102657857B (zh) | 一种利用沙鼠肾细胞制备肠道病毒疫苗的方法 | |
| CN1843507B (zh) | 一种人用腮腺炎病毒组份疫苗及其制备方法和应用 | |
| Hsu | Cell fusion induced by a plant virus | |
| RU2509571C1 (ru) | Способ получения вакцины против парагриппа-3 крупного рогатого скота | |
| US20240229007A1 (en) | Inactivated vaccines & nucleic acid aptamer therapeutics derived therefrom | |
| WO2018012498A1 (ja) | リアソータントインフルエンザウイルス作出方法 | |
| CN120192936A (zh) | 一种高剂量流感病毒裂解疫苗原液的制备方法 | |
| TH58373A (th) | อิมมูโนเจนที่ถูกเพิ่มกำลัง สำหรับวัคซีนเชื้อตายเพื่อต่อสู้กับโรคที่เป็นการติดเชื้อ ที่มีสาเหตุมาจากกลุ่มของเจเปเนส เอนซีฟาไลทีสไวรัสและวิธีการเพื่อผลิตสิ่งนั้น | |
| TH35753B (th) | อิมมูโนเจนที่ถูกเพิ่มกำลัง สำหรับวัคซีนเชื้อตายเพื่อต่อสู้กับโรคที่เป็นการติดเชื้อ ที่มีสาเหตุมาจากกลุ่มของเจเปเนส เอนซีฟาไลทีสไวรัสและวิธีการเพื่อผลิตสิ่งนั้น |